
Sign up to save your podcasts
Or


Barron's senior managing editor Lauren R. Rublin and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for biotech and pharma stocks, Alzheimer's and weight-loss treatments, and second-quarter earnings.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Barron's Live3.8
206206 ratings
Barron's senior managing editor Lauren R. Rublin and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for biotech and pharma stocks, Alzheimer's and weight-loss treatments, and second-quarter earnings.
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,227 Listeners

1,730 Listeners

953 Listeners

536 Listeners

981 Listeners

201 Listeners

1,042 Listeners

356 Listeners

378 Listeners

212 Listeners

188 Listeners

70 Listeners

1,314 Listeners

1,583 Listeners

113 Listeners

74 Listeners

86 Listeners

20 Listeners

46 Listeners